Risultati della ricerca - Yen‐Hung Lin
- Mostra 1 - 20 risultati su 39
- Vai alla pagina seguente
-
1
-
2
-
3
-
4
Left ventricular remodeling and dysfunction in primary aldosteronism di Cheng‐Hsuan Tsai, Chien‐Ting Pan, Yi‐Yao Chang, Zheng‐Wei Chen, Vin‐Cent Wu, Chi‐Sheng Hung, Yen‐Hung Lin
Pubblicazione 2020Revisão -
5
Pathophysiology and blood pressure measurements of hypertension in the elderly di Fan-Yu Chen, Chun‐Wei Lee, Yu-Jen Chen, Yen-Hung Lin, Chih‐Fan Yeh, Chih‐Ching Lin, Hao-Min Cheng
Pubblicazione 2025Revisão -
6
Clinical Outcome and Cost-Effectiveness of a Synchronous Telehealth Service for Seniors and Nonseniors with Cardiovascular Diseases: Quasi-Experimental Study di Ying‐Hsien Chen, Yen‐Hung Lin, Chi‐Sheng Hung, Ching‐Chang Huang, Deng-Feng Yeih, Pao‐Yu Chuang, Yi‐Lwun Ho, Ming-Fong Chen
Pubblicazione 2013Artigo -
7
Endothelial Dysfunction in Primary Aldosteronism di Zheng‐Wei Chen, Cheng‐Hsuan Tsai, Chien‐Ting Pan, Chia‐Hung Chou, Che‐Wei Liao, Chi‐Sheng Hung, Vin‐Cent Wu, Yen‐Hung Lin
Pubblicazione 2019Revisão -
8
-
9
-
10
Assessment of the Cost-Effectiveness and Clinical Outcomes of a Fourth-Generation Synchronous Telehealth Program for the Management of Chronic Cardiovascular Disease di Yi‐Lwun Ho, Jiun-Yu Yu, Yen‐Hung Lin, Ying‐Hsien Chen, Ching‐Chang Huang, Tse‐Pin Hsu, Pao‐Yu Chuang, Chi‐Sheng Hung, Ming-Fong Chen
Pubblicazione 2014Artigo -
11
Postprandial Glucose Improves the Risk Prediction of Cardiovascular Death Beyond the Metabolic Syndrome in the Nondiabetic Population di Hung‐Ju Lin, Bai‐Chin Lee, Yi‐Lwun Ho, Yen‐Hung Lin, Ching‐Yi Chen, Hsiu‐Ching Hsu, Mao‐Shin Lin, Kuo‐Liong Chien, Ming-Fong Chen
Pubblicazione 2009Artigo -
12
-
13
Long term outcome of Aldosteronism after target treatments di Vin‐Cent Wu, Shuo‐Meng Wang, Chia‐Hui Chang, Ya‐Hui Hu, Lian‐Yu Lin, Yen‐Hung Lin, Shih‐Chieh Chueh, Shuo‐Meng Wang, Kwan‐Dun Wu
Pubblicazione 2016Artigo -
14
Blood pressure targets, medication considerations and special concerns in elderly hypertension III: Focus on stroke and neurodegenerative disorders di Cheng‐Hsuan Li, Sung‐Ju Hsueh, Li‐Kai Tsai, Wei Hung Chang, Shao‐Yi Cheng, Hao‐Min Cheng, Chih‐Fan Yeh, Yen-Hung Lin, Hsin‐Hsi Tsai
Pubblicazione 2025Revisão -
15
-
16
-
17
Presence of Subclinical Hypercortisolism in Clinical Aldosterone-Producing Adenomas Predicts Lower Clinical Success di Kang‐Yung Peng, Hung‐Wei Liao, Chieh‐Kai Chan, Wei‐Chou Lin, Shao‐Yu Yang, Yao‐Chou Tsai, Kuo‐How Huang, Yen‐Hung Lin, Shih‐Chieh Chueh, Vin‐Cent Wu
Pubblicazione 2020Artigo -
18
Tafamidis Treatment Decreases 99mTc-Pyrophosphate Uptake in Patients With Hereditary Ala97Ser Transthyretin Amyloid Cardiomyopathy di An‐Li Yu, Yi‐Chieh Chen, Cheng‐Hsuan Tsai, Chi‐Chao Chao, Mao‐Yuan Su, Jimmy Jyh-Ming Juang, Ming‐Jen Lee, Sung‐Tsang Hsieh, Mei‐Fang Cheng, Yen‐Hung Lin
Pubblicazione 2023Carta -
19
Influence of Non-Alcoholic Fatty Liver Disease on Autonomic Changes Evaluated by the Time Domain, Frequency Domain, and Symbolic Dynamics of Heart Rate Variability di Yu‐Chen Liu, Chi-Sheng Hung, Yen‐Wen Wu, Yi-Chin Lee, Yen‐Hung Lin, Chen Lin, Men‐Tzung Lo, Chun-Chieh Chan, Hsi-Pin Ma, Yi‐Lwun Ho, Chien‐Hung Chen
Pubblicazione 2013Artigo -
20
Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society... di Paolo Mulatero, Silvia Monticone, Jaap Deinum, Laurence Amar, Aleksander Prejbisz, Maria‐Christina Zennaro, Felix Beuschlein, Gian Paolo Rossi, Tetsuo Nishikawa, Alberto Morganti, Teresa Maria Seccia, Yen‐Hung Lin, Francesco Fallo, J Widimský
Pubblicazione 2020Artigo
Strumenti per la ricerca:
Soggetti correlati
Medicine
Internal medicine
Aldosterone
Cardiology
Primary aldosteronism
Blood pressure
Endocrinology
Adrenalectomy
Biology
Urology
Adenoma
Confidence interval
Heart failure
Hyperaldosteronism
Biochemistry
Disease
Environmental health
Gastroenterology
Hazard ratio
Mineralocorticoid receptor
Population
Secondary hypertension
Essential hypertension
Fibrosis
Gene
Genetics
Intensive care medicine
Mineralocorticoid
Proportional hazards model
Renin–angiotensin system